## SLAB: Silicon Laboratories, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 0.9% below STRENGTH zone (4.0-10.0%); PEG 3.03 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($125.11)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Silicon Labs (SLAB): Assessing Valuation After a Recent 14% Oneâ€‘Month Share Price Rebound**
- Source: Simply Wall Street | 20251219T090935 | Somewhat-Bullish | Relevance: 100%
- Silicon Laboratories has seen a 14% share price rebound over the last month, prompting a re-evaluation of its valuation. While a "narrative" perspective suggests it's 10.6% undervalued with a fair value of $150.44 due to new wireless platforms, a "multiples" view indicates a richer price point with a 5.9x price-to-sales ratio compared to peers. Investors are encouraged to assess these different perspectives and consider the potential risks from increased competition.

**2. Thrivent Financial for Lutherans Sells 20,718 Shares of Silicon Laboratories, Inc. $SLAB**
- Source: MarketBeat | 20251219T103335 | Neutral | Relevance: 100%
- Thrivent Financial for Lutherans reduced its stake in Silicon Laboratories, Inc. (NASDAQ:SLAB) by 27.7% during the second quarter, selling 20,718 shares and retaining 54,130 shares valued at $7,977,000. Other institutional investors like Jones Financial Companies Lllp and Canada Pension Plan Investment Board increased their holdings. Silicon Laboratories reported Q3 earnings per share of $0.32, surpassing analyst estimates, and has a "Hold" consensus rating from Wall Street analysts.

**3. Zacks.com featured highlights include QuantumScape, Adobe and Silicon Laboratories**
- Source: Nasdaq | 20251217T100859 | Bullish | Relevance: 94%
- This article highlights QuantumScape Corp. (QS), Adobe Inc. (ADBE), and Silicon Laboratories Inc. (SLAB) as top stocks poised for impressive earnings acceleration in 2026. Earnings acceleration, defined as incremental growth in EPS, is presented as a strong indicator of future stock price increases. The article also provides a brief overview of each company and their expected earnings growth rates.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 3 ($0.02M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 59.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- FMR, LLC: 15.0% (+0.8%)
- Blackrock Inc.: 13.7% (+2.5%)
- Vanguard Group Inc: 11.8% (+1.9%)
- State Street Corpora: 4.7% (+2.4%)
- Macquarie Group Limi: 3.0% (-8.6%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.9% 5d) with bearish MACD, trend may be turning.
2. Valuation stretched: PEG 3.0x requires aggressive growth execution.
3. Elevated short interest (9.4%): bears positioning against stock.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.03 signals overvaluation risk, limited margin of safety. Forward P/E 50.2x attractive for 197% earnings growth. Balance sheet: strong liquidity (4.5x), low leverage (D/E 0.17). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $4.4B |
| Beta | 1.56 |
| 52W Range | $82.82 - $160.00 |
| Short Interest | 9.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.03 |
| Forward P/E | 50.2 |
| Current P/E | 149.1 |
| YoY Growth | 197.1% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 3.8% to 0.9% (-2.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.1pp (needs >4.0% for momentum thesis). MRS_5 (-0.5%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 53. Elevated volume (1.4x 20MA), institutional activity likely. OFD pattern: -DUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.87% (CS: 60) | Neutral |
| RSI_14 | 53.0 | Neutral |
| MACD Histogram | -0.33 | Bearish |
| vs SMA20 | 1.011x | Above |
| vs SMA50 | 1.032x | Above |
| vs SMA200 | 1.054x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $135.03
- **Stop Loss:** $125.11 (7.3% risk)
- **Target:** $144.95 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 120
- **Position Value:** $16,203.60
- **Portfolio %:** 16.20%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-03 (Est: $0.55)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.31 | $0.32 | +4.2% |
| 2025Q2 | $0.09 | $0.11 | +18.7% |
| 2025Q1 | $-0.09 | $-0.08 | +10.9% |
| 2024Q4 | $-0.11 | $-0.11 | -1.6% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*